Varian wins FDA IDE for Flash radiation therapy
Varian announced today that it received FDA investigational device exemption to advance its Flash clinical research program.
Source: massdevice.com
Stay updated with breaking news from Flashforward Consortium. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Varian announced today that it received FDA investigational device exemption to advance its Flash clinical research program.
An investigational treatment approach that may help us move beyond the limitations of normal tissue tolerance to radiation is clinically feasible for the first time. If successful, it could lead to profound changes in cancer care.
/PRNewswire/ -- Varian, a Siemens Healthineers company, and the Cincinnati Children's/UC Health Proton Therapy Center today announced the completion of...